bacteria

Fischbach and Desai focus on “micro” solutions to improve health with drugs

Faculty members in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, share their research on the human microbiome and microfabricated drug delivery systems and their hopes for how their science will improve the health of patients.

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support
Research stalwarts draw funding for decades
New directions in translational research attract support
Expansion of the School’s...

Logic gates allow bacteria to work like computers

Logic gates, similar to those that form the basis of silicon computing, can now be inserted into bacteria via genetic engineering, making it possible to manipulate bacteria to perform complicated tasks. This finding will ultimately enable cells to be programmed with more intricate functions,...

Fujimori unveils enzymatic process in bacteria that leads to antibiotic resistance

Research results published from the UCSF research laboratory of Danica Galonić Fujimori, PhD, have revealed a radical approach employed by bacteria to alter their ribosomes and thereby evade antibiotics. These findings could ultimately lead to the development of ways to block this enzymatic...

Study reveals how to make gasoline from yeast and bacterium

A chemical precursor molecule of gasoline can be produced from biomass and salt, according to research by UCSF School of Pharmacy's Christopher Voigt, PhD, and UCSF colleagues.

Voigt and synthetic biology: art meets calculus

Christopher A. Voigt, PhD, faculty member in the UCSF School of Pharmacy, is studying how to engineer living systems to solve widespread problems of society, such as our dependence on petroleum-based fuels.

Voigt pioneers field of synthetic biology

Christopher A. Voigt, PhD, UCSF School of Pharmacy scientist, and colleagues are engineering bacteria to target tumors and create images. This work is part of the emerging field of synthetic biology, which aims to create new biological parts, systems, and tools, and redesign existing biological...